Clinical Trials Logo

Smoking clinical trials

View clinical trials related to Smoking.

Filter by:

NCT ID: NCT02763527 Not yet recruiting - Smoking Clinical Trials

Effectiveness of Negotiating Self-determination to Reduce Cigarette Consumption

Start date: June 2021
Phase: N/A
Study type: Interventional

Background: Smokers attended to outpatient clinics present an excellent 'teachable moment' for smoking cessation interventions. This protocol paper describes the rationale and methods of a large randomized controlled trial which aims to evaluate the effectiveness of negotiating self-determination to reduce cigarette consumption among smokers attending outpatient clinics Methods: A randomized controlled trial will be conducted in 10 out-patient clinics in Hong Kong. Subjects in the intervention group will receive a brief intervention on smoking reduction plus a smoking reduction leaflet. Additionally, subjects will be asked to think about a smoking reduction schedule for themselves after the negotiation with the counsellor. Subjects in the control group will receive a brief advice on quitting plus a leaflet on smoking cessation. Four consecutive (1, 3, 6 and 12 months) follow-ups will be conducted. The primary outcome measure is biochemically validated abstinence at 6 months. Secondary outcomes are: (i) biochemically validated abstinence at 12 months, (ii) self-reported 7-day point prevalence of abstinence at 6 and 12 months, (iii) self-reported reduction of ≥ 50% in cigarette consumption at 6 and 12 months, and (iv) self-efficacy against tobacco at 6 and 12 months.

NCT ID: NCT02752022 Active, not recruiting - Smoking Clinical Trials

Monitoring the Transition From Smoking to E-cigarettes

Start date: September 2016
Phase:
Study type: Observational

Electronic cigarettes (e-cigarettes) have proved very popular and a meteoric rise in their usage is currently under way. People purchase them as an aid to giving up smoking, to reduce cigarette consumption, to minimise withdrawal symptoms in occupational environments that ban smoking, and in order to continue smoking with decreased health risks. Although the safety and impact on health of electronic cigarettes, especially after long-term use, has not been evaluated, they are generally considered to be far safer alternatives to cigarette smoke. Electronic cigarettes do not generate polycyclic aromatic hydrocarbons, a potent class of carcinogenic chemicals generated during the combustion of tobacco and making important contribution to the cigarette-induced cancer. However, carcinogenic tobacco-specific nitrosamines have been encountered in e-cigarettes being detected in some nicotine cartridges as contaminants, albeit at very low concentrations in comparison with tobacco smoke. Consequently, it is imperative to ascertain the toxicity risk (if any) of consuming nicotine intake through electronic cigarettes. This European Commission funded study will monitor levels of carcinogenic tobacco-specific nitrosamines in urine of heavy smokers who give up smoking and completely transition to e-cigarette use for a period of 4 weeks. Levels of other compounds which are known to be associated with smoking toxicity, such as DNA adducts and DNA methylation, will also be monitored in biological fluids of these subjects. Finally, cigarette craving, mood, anxiety, social anxiety, well-being status and stress hormones will be measured in smokers transitioning to e-cigarettes for 4 weeks to assess the psychological effect of the transition. The results from the study will provide important information on the safety and effectiveness of e-cigarettes for smoking cessation which investigators anticipate to drive policy.

NCT ID: NCT02750904 Completed - Bipolar Disorder Clinical Trials

Web-Delivered Acceptance & Commitment Therapy for Smokers With Bipolar Disorder

WebQuit Plus
Start date: April 3, 2017
Phase: N/A
Study type: Interventional

This purpose of the study is to develop and test a new website to help people who have bipolar disorder quit smoking.

NCT ID: NCT02750020 Completed - Smoking Clinical Trials

Policy-related Survey on Tobacco Control

Start date: February 2016
Phase:
Study type: Observational

Current study is the fourth wave of the policy-related survey on tobacco control in Hong Kong. It aims to investigate the level of public support on current and future tobacco control measures and taxation policies and to address the timely impacts of smoke-free policies, substantiate public support on further tobacco control measures and assist COSH in shaping policy direction for government. In total, 5000 subjects will be randomly selected for a telephone interview. The subjects will be categorized into three groups, i.e. never smokers (1667), ex-smokers (1667) and current smokers (1667). They will be required to answer a questionnaire via telephone. All data shall be collected using a Computer Assisted Telephone Interview (CATI) system, which allows real-time data capture and consolidation. All interviews shall be conducted anonymously. Analysis of survey data will aim to identify current opinion on tobacco control policies and implications for future policies. Analyses will be controlled for confounding variables as required by stratification into sub-groups based on important pre-defined characteristics and/or by multivariate analysis. Comparison with past trends and, where possible, extrapolation of future trends will be explored. Weights will be applied to adjust for the sex and age of Hong Kong population, and to handle the over-sampling issues of current smokers. The data analysis will be conducted by statisticians.

NCT ID: NCT02737358 Completed - Smoking Clinical Trials

N-acetylcysteine for Tobacco Use Disorder

Start date: August 30, 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the effects of administering N-Acetylcysteine (NAC) to assist in initial cessation and/or relapse prevention in adult cigarette smokers.

NCT ID: NCT02730676 Completed - Smoking Clinical Trials

Comparison of Pharmacokinetic Parameters Between Adopters of Electronic Cigarettes and a Historical Sample of Combustible Cigarette Smokers

Start date: April 2016
Phase:
Study type: Observational

This study assesses the nicotine pharmacokinetic (PK) parameters in adopters of electronic cigarettes following a 12-hour tobacco and nicotine abstinence. The PK results of this study will be compared to historical data on smokers obtained in prior studies, as well as on naïve and short-term users of electronic cigarettes.

NCT ID: NCT02724462 Completed - Smoking Clinical Trials

Trial of An Innovative Smartphone Intervention for Smoking Cessation

Start date: May 27, 2017
Phase: N/A
Study type: Interventional

The goal of this study is to determine whether the novel smartphone app (SmartQuit) provides higher quit rates than the current standard smoking cessation app.

NCT ID: NCT02718872 Completed - Smoking Cessation Clinical Trials

Tobacco Cessation Training Program in Spanish-speaking Countries

FRUITFUL
Start date: January 2015
Phase: N/A
Study type: Interventional

This project is responsive to the identified gap of lack of tobacco cessation training programs in Latin American & Caribbean countries. Currently, smoking rates in the Latin American and Caribbean region are high, and previous surveys show that health professionals do not have enough skills to help smokers to quit. In consequence, in absence of trained health professionals, many smokers who visit health care services are under-treated. The Fruitful Project aims to adapt an original on-line course developed in Spain to the reality of the three Latin American countries (Bolivia, Guatemala and Paraguay) and disseminate evidence-based tobacco cessation interventions among health care professionals.

NCT ID: NCT02713594 Completed - Smoking Cessation Clinical Trials

Wisconsin Tobacco Quit Line Medicaid Incentive Evaluation

Start date: April 2013
Phase: N/A
Study type: Interventional

The study is designed to test the hypotheses that financial incentives can increase both participation in smoking cessation treatment and resulting cessation rates, when they are offered to BadgerCare Plus (Medicaid) smokers as part of their health care.

NCT ID: NCT02701686 Completed - Smoking Clinical Trials

A Comparison of the Effectiveness of Two Approaches in Achieving Smoking Abstinence

Start date: June 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to test the effectiveness of negotiating self determination to reduce cigarette consumption. A single-blinded multi-centre randomized controlled is employed.